Coronary interventions Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Høj Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M December 6, 2019 | 10.4244/EIJ-D-19-00503
Coronary interventions 10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Høj Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M August 20, 2019 | 10.4244/EIJ-D-19-00503
Interventions for heart failure Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model Moller-Helgestad OK, Hyldebrandt JA, Banke A, Rud CS, Udesen NLJ, Linde L, Okkels Jensen L, Schmidt H, Ravn HB, Moller JE February 7, 2019 | 10.4244/EIJ-D-18-00684
Coronary interventions Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial) Katagiri Y, Onuma Y, Asano T, Iniguez A, Okkels Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P December 7, 2018 | 10.4244/EIJ-D-18-00839
STEMI One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis Hansen KN, Bendix K, Antonsen L, Veien K, Maeng M, Junker A, Christiansen EH, Kahlert J, Terkelsen C, Christensen LB, Fallesen C, Bøtker H, Okkels Jensen L October 19, 2018 | 10.4244/EIJ-D-17-00800
Interventions for heart failure Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest Ellert J, Jensen MJ, Okkels Jensen L, Moller JE April 6, 2018 | 10.4244/EIJ-D-17-00637
How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection? Fallesen C, Antonsen L, Thayssen P, Okkels Jensen L February 20, 2018 | 10.4244/EIJ-D-17-00309
Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial) Okkels Jensen L, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, Hansen H, Flensted Lassen J, Bøtker H, Christiansen E January 19, 2018 | 10.4244/EIJ-D-17-00731
Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents Jakobsen L, Christiansen E, Maeng M, Hansen K, Kristensen SD, Bøtker H, Terkelsen C, Jensen S, Raungaard B, Madsen M, Flensted Lassen J, Okkels Jensen L December 20, 2017 | 10.4244/EIJ-D-17-00434
Coronary interventions Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study Räber L, Onuma Y, Brugaletta S, Garcia-Garcia H, Backx B, Iñiguez A, Okkels Jensen L, Cequier-Fillat A, Pilgrim T, Høj Christiansen E, Hofma S, Suttorp M, Serruys P, Sabaté M, Windecker S July 20, 2016 | 10.4244/EIJY15M08_03
Coronary interventions Outcome with invasive versus medical treatment of stable coronary artery disease: influence of perfusion defect size, ischaemia, and ejection fraction Simonsen J, Johansen A, Gerke O, Mickley H, Thomassen A, Hess S, Rask C, Tamadoni M, Okkels Jensen L, Hallas J, Vach W, Hoilund-Carlsen P February 19, 2016 | 10.4244/EIJV11I10A226
Very late stent thrombosis caused by neoatherosclerotic plaque rupture Hougaard M, Thayssen P, Hansen H, Okkels Jensen L April 20, 2015 | 10.4244/EIJV10I12A251
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial Antonsen L, Thayssen P, Hansen H, Maeng M, Tilsted H, Bøtker H, Ravkilde J, Madsen M, Sørensen H, Thuesen L, Flensted Lassen J, Okkels Jensen L June 20, 2014 | 10.4244/EIJV10I2A35
Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial Egede R, Okkels Jensen L, Hansen H, Hansen K, Junker A, Thayssen P February 22, 2013 | 10.4244/EIJV8I10A182
Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention Jakobsen L, Niemann T, Thorsgaard N, Nielsen T, Thuesen L, Flensted Lassen J, Okkels Jensen L, Thayssen P, Ravkilde J, Tilsted H, Mehnert F, Johnsen SP December 28, 2012 | 10.4244/EIJV8I8A139
The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation Thayssen P, Okkels Jensen L, Flensted Lassen J, Tilsted H, Kaltoft A, Christiansen E, Hansen K, Ravkilde J, Maeng M, Krusell L, Madsen M, Sørensen H, Thuesen L September 28, 2012 | 10.4244/EIJV8I5A91
Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease Okkels Jensen L, Thayssen P, Farkas D, Hougaard M, Terkelsen C, Tilsted H, Maeng M, Junker A, Flensted Lassen J, Horv E, Sørensen H, Thuesen L August 24, 2012 | 10.4244/EIJV8I4A72
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial Okkels Jensen L, Maeng M, Thayssen P, Villadsen A, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen E, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Flensted Lassen J, Thuesen L July 29, 2011 | 10.4244/EIJV7I3A56
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes Okkels Jensen L, Tilsted H, Thayssen P, Kaltoft A, Maeng M, Flensted Lassen J, Noerregaard Hansen K, Madsen M, Ravkilde J, Johnsen S, Sørensen H, Thuesen L April 12, 2010
Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-tomoderate coronary atherosclerosis: an international multicentre study Huisman J, Egede R, Rdzanek A, Böse D, Erbel R, Kochman J, Okkels Jensen L, Van de Palen J, Hartmann M, Mintz G, von Birgelen C April 12, 2010
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years (The Trials book is supported by Biotronik) December 13, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019